Paras Healthcare jumps to record after IPO debut and Buy call
In short
Paras Healthcare shares rose 5.4% to a record ₹777 after an early dip. The stock had listed at a 3.9% premium to its ₹693 IPO price, and Choice Institutional Equities started coverage with a Buy rating and a ₹900 target.
This matters because investors are reacting to the company’s listing and the broker’s positive view. The reporting does not say how long the rally will last or whether the target will be met.
What the reporting says
Paras Healthcare shares rose 5.4% to a record ₹777 after an early dip, following a market debut at a 3.9% premium to its ₹693 IPO price. Choice Institutional Equities initiated coverage with a Buy rating and a ₹900 target, citing growth in specialised care and operational improvements. The immediate consequence was a stronger stock price, while the longer-term execution outlook remains the market’s focus.
Why it matters
Paras Healthcare shares rose 5.4% to a record ₹777 after an early dip, following a debut at a 3.9% premium to its ₹693 IPO price. Choice Institutional Equities started coverage with a Buy rating and a ₹900 target, citing growth in specialised care and operational improvements. The summary does not provide details on listing volumes, profit outlook, or how quickly the stock may reach the target.